Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Camitta

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Blood|October 1, 1989
Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblingsB Camitta, R Ash, J Menitove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
Transplantation|February 1, 1976
Detection of genetically determined histocompatibility antigen differences between HL-A identical and MLC nonreactive siblingsR Parkman, F S Rosen, J Rappeport, et al.
Cancer|November 15, 1990
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group studyC K Tebbi, J Krischer, D J Fernbach, et al.
Leukemia|October 29, 2004
Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trialS Jeha, H Kantarjian, D Irwin, et al.
Bone Marrow Transplantation|October 31, 2002
Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal studyM J Kupst, B Penati, B Debban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II studyC P Steuber, J Krischer, T Holbrook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trialD H Mahoney, J Shuster, R Nitschke, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapyK Longeway, R Mulhern, J Crisco, et al.
Leukemia|July 30, 2003
Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group studyM J Borowitz, D J Pullen, J J Shuster, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Blood|October 1, 1989
Bone marrow transplantation for children with severe aplastic anemia: use of donors other than HLA-identical siblingsB Camitta, R Ash, J Menitove, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group studyD H Mahoney, J J Shuster, R Nitschke, et al.
Transplantation|February 1, 1976
Detection of genetically determined histocompatibility antigen differences between HL-A identical and MLC nonreactive siblingsR Parkman, F S Rosen, J Rappeport, et al.
Cancer|November 15, 1990
Toxicity of high-dose cytosine arabinoside in the treatment of advanced childhood tumors resistant to conventional therapy. A Pediatric Oncology Group studyC K Tebbi, J Krischer, D J Fernbach, et al.
Leukemia|October 29, 2004
Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: final results of a multicenter compassionate use trialS Jeha, H Kantarjian, D Irwin, et al.
Bone Marrow Transplantation|October 31, 2002
Cognitive and psychosocial functioning of pediatric hematopoietic stem cell transplant patients: a prospective longitudinal studyM J Kupst, B Penati, B Debban, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Therapy of refractory or recurrent childhood acute myeloid leukemia using amsacrine and etoposide with or without azacitidine: a Pediatric Oncology Group randomized phase II studyC P Steuber, J Krischer, T Holbrook, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trialD H Mahoney, J Shuster, R Nitschke, et al.
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Treatment of meningeal relapse in childhood acute lymphoblastic leukemia: II. A prospective study of intellectual loss specific to CNS relapse and therapyK Longeway, R Mulhern, J Crisco, et al.
Leukemia|July 30, 2003
Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group studyM J Borowitz, D J Pullen, J J Shuster, et al.
Pageof 8